nodes	percent_of_prediction	percent_of_DWPC	metapath
Dorzolamide—CYP2C9—Vismodegib—skin cancer	0.121	0.236	CbGbCtD
Dorzolamide—CYP3A4—Imiquimod—skin cancer	0.102	0.198	CbGbCtD
Dorzolamide—CYP3A4—Temozolomide—skin cancer	0.102	0.198	CbGbCtD
Dorzolamide—CYP3A4—Vismodegib—skin cancer	0.0705	0.137	CbGbCtD
Dorzolamide—CYP3A4—Vemurafenib—skin cancer	0.0557	0.109	CbGbCtD
Dorzolamide—CYP2C9—Fluorouracil—skin cancer	0.043	0.0839	CbGbCtD
Dorzolamide—CYP3A4—Docetaxel—skin cancer	0.0191	0.0373	CbGbCtD
Dorzolamide—CA6—ear—skin cancer	0.0166	0.187	CbGeAlD
Dorzolamide—CA6—hair follicle—skin cancer	0.00877	0.0987	CbGeAlD
Dorzolamide—CA1—nerve—skin cancer	0.00556	0.0626	CbGeAlD
Dorzolamide—CA5A—female reproductive system—skin cancer	0.00461	0.0519	CbGeAlD
Dorzolamide—CA4—nerve—skin cancer	0.00435	0.0489	CbGeAlD
Dorzolamide—CA2—hair follicle—skin cancer	0.00302	0.034	CbGeAlD
Dorzolamide—CA12—connective tissue—skin cancer	0.00283	0.0318	CbGeAlD
Dorzolamide—CA9—female reproductive system—skin cancer	0.0027	0.0303	CbGeAlD
Dorzolamide—CA6—head—skin cancer	0.00248	0.028	CbGeAlD
Dorzolamide—CA4—nipple—skin cancer	0.00247	0.0278	CbGeAlD
Dorzolamide—CA4—neck—skin cancer	0.00244	0.0275	CbGeAlD
Dorzolamide—CA5B—mammalian vulva—skin cancer	0.00209	0.0235	CbGeAlD
Dorzolamide—CA2—nipple—skin cancer	0.00205	0.023	CbGeAlD
Dorzolamide—CA2—neck—skin cancer	0.00203	0.0228	CbGeAlD
Dorzolamide—CA12—female reproductive system—skin cancer	0.00199	0.0224	CbGeAlD
Dorzolamide—CA5B—female reproductive system—skin cancer	0.00179	0.0201	CbGeAlD
Dorzolamide—CA12—head—skin cancer	0.00167	0.0187	CbGeAlD
Dorzolamide—CA1—lymphoid tissue—skin cancer	0.00164	0.0184	CbGeAlD
Dorzolamide—CA1—female reproductive system—skin cancer	0.00158	0.0178	CbGeAlD
Dorzolamide—CA5B—head—skin cancer	0.00149	0.0168	CbGeAlD
Dorzolamide—CA2—connective tissue—skin cancer	0.00145	0.0163	CbGeAlD
Dorzolamide—CA2—epithelium—skin cancer	0.00138	0.0155	CbGeAlD
Dorzolamide—CA1—head—skin cancer	0.00132	0.0149	CbGeAlD
Dorzolamide—CA2—skin of body—skin cancer	0.00131	0.0148	CbGeAlD
Dorzolamide—CA4—female reproductive system—skin cancer	0.00123	0.0139	CbGeAlD
Dorzolamide—CA2—mammalian vulva—skin cancer	0.0012	0.0135	CbGeAlD
Dorzolamide—CA2—lymphoid tissue—skin cancer	0.00106	0.0119	CbGeAlD
Dorzolamide—CA5B—lymph node—skin cancer	0.00105	0.0118	CbGeAlD
Dorzolamide—CA4—head—skin cancer	0.00103	0.0116	CbGeAlD
Dorzolamide—CA2—female reproductive system—skin cancer	0.00102	0.0115	CbGeAlD
Dorzolamide—Discomfort—Imiquimod—skin cancer	0.000957	0.0024	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Dactinomycin—skin cancer	0.000956	0.0024	CcSEcCtD
Dorzolamide—Dry mouth—Imiquimod—skin cancer	0.000947	0.00238	CcSEcCtD
Dorzolamide—Decreased appetite—Vemurafenib—skin cancer	0.000946	0.00238	CcSEcCtD
Dorzolamide—Bronchitis—Temozolomide—skin cancer	0.000941	0.00236	CcSEcCtD
Dorzolamide—Fatigue—Vemurafenib—skin cancer	0.000939	0.00236	CcSEcCtD
Dorzolamide—Oedema—Imiquimod—skin cancer	0.000929	0.00233	CcSEcCtD
Dorzolamide—CA1—lymph node—skin cancer	0.000924	0.0104	CbGeAlD
Dorzolamide—Pulmonary oedema—Docetaxel—skin cancer	0.000923	0.00232	CcSEcCtD
Dorzolamide—Dysuria—Temozolomide—skin cancer	0.000915	0.0023	CcSEcCtD
Dorzolamide—Shock—Imiquimod—skin cancer	0.000914	0.00229	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Temozolomide—skin cancer	0.000909	0.00228	CcSEcCtD
Dorzolamide—Erectile dysfunction—Temozolomide—skin cancer	0.000901	0.00226	CcSEcCtD
Dorzolamide—Agranulocytosis—Dactinomycin—skin cancer	0.0009	0.00226	CcSEcCtD
Dorzolamide—Hyperhidrosis—Imiquimod—skin cancer	0.000898	0.00225	CcSEcCtD
Dorzolamide—Weight decreased—Temozolomide—skin cancer	0.000885	0.00222	CcSEcCtD
Dorzolamide—Anorexia—Imiquimod—skin cancer	0.000885	0.00222	CcSEcCtD
Dorzolamide—Hyperglycaemia—Temozolomide—skin cancer	0.000883	0.00222	CcSEcCtD
Dorzolamide—Angina pectoris—Fluorouracil—skin cancer	0.000878	0.0022	CcSEcCtD
Dorzolamide—Depression—Temozolomide—skin cancer	0.00087	0.00218	CcSEcCtD
Dorzolamide—CYP2C9—female reproductive system—skin cancer	0.000866	0.00975	CbGeAlD
Dorzolamide—Stevens-Johnson syndrome—Temozolomide—skin cancer	0.000865	0.00217	CcSEcCtD
Dorzolamide—Body temperature increased—Vemurafenib—skin cancer	0.000861	0.00216	CcSEcCtD
Dorzolamide—Pharyngitis—Dactinomycin—skin cancer	0.000859	0.00216	CcSEcCtD
Dorzolamide—CA2—head—skin cancer	0.000855	0.00963	CbGeAlD
Dorzolamide—Urinary tract infection—Temozolomide—skin cancer	0.000848	0.00213	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Imiquimod—skin cancer	0.000846	0.00212	CcSEcCtD
Dorzolamide—Insomnia—Imiquimod—skin cancer	0.00084	0.00211	CcSEcCtD
Dorzolamide—Upper respiratory tract infection—Fluorouracil—skin cancer	0.000838	0.0021	CcSEcCtD
Dorzolamide—Paraesthesia—Imiquimod—skin cancer	0.000834	0.00209	CcSEcCtD
Dorzolamide—Cardiac failure congestive—Docetaxel—skin cancer	0.00083	0.00208	CcSEcCtD
Dorzolamide—Dyspnoea—Imiquimod—skin cancer	0.000828	0.00208	CcSEcCtD
Dorzolamide—Somnolence—Imiquimod—skin cancer	0.000825	0.00207	CcSEcCtD
Dorzolamide—Alopecia—Bleomycin—skin cancer	0.00082	0.00206	CcSEcCtD
Dorzolamide—Erythema multiforme—Dactinomycin—skin cancer	0.000819	0.00206	CcSEcCtD
Dorzolamide—Sinusitis—Temozolomide—skin cancer	0.000819	0.00205	CcSEcCtD
Dorzolamide—Dyspepsia—Imiquimod—skin cancer	0.000817	0.00205	CcSEcCtD
Dorzolamide—Erythema—Bleomycin—skin cancer	0.000808	0.00203	CcSEcCtD
Dorzolamide—Decreased appetite—Imiquimod—skin cancer	0.000807	0.00203	CcSEcCtD
Dorzolamide—Hypersensitivity—Vemurafenib—skin cancer	0.000802	0.00201	CcSEcCtD
Dorzolamide—Fatigue—Imiquimod—skin cancer	0.000801	0.00201	CcSEcCtD
Dorzolamide—Visual disturbance—Docetaxel—skin cancer	0.000794	0.00199	CcSEcCtD
Dorzolamide—Pain—Imiquimod—skin cancer	0.000794	0.00199	CcSEcCtD
Dorzolamide—Acute coronary syndrome—Fluorouracil—skin cancer	0.000792	0.00199	CcSEcCtD
Dorzolamide—Myocardial infarction—Fluorouracil—skin cancer	0.000788	0.00198	CcSEcCtD
Dorzolamide—Conjunctivitis—Fluorouracil—skin cancer	0.000781	0.00196	CcSEcCtD
Dorzolamide—Urinary tract infection—Fluorouracil—skin cancer	0.000781	0.00196	CcSEcCtD
Dorzolamide—Asthenia—Vemurafenib—skin cancer	0.000781	0.00196	CcSEcCtD
Dorzolamide—Hallucination—Temozolomide—skin cancer	0.000779	0.00196	CcSEcCtD
Dorzolamide—Pharyngitis—Temozolomide—skin cancer	0.000777	0.00195	CcSEcCtD
Dorzolamide—Cardiac failure—Docetaxel—skin cancer	0.000771	0.00194	CcSEcCtD
Dorzolamide—Pruritus—Vemurafenib—skin cancer	0.00077	0.00193	CcSEcCtD
Dorzolamide—Alopecia—Dactinomycin—skin cancer	0.000765	0.00192	CcSEcCtD
Dorzolamide—Feeling abnormal—Imiquimod—skin cancer	0.000765	0.00192	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Imiquimod—skin cancer	0.000759	0.00191	CcSEcCtD
Dorzolamide—Epistaxis—Fluorouracil—skin cancer	0.000758	0.0019	CcSEcCtD
Dorzolamide—Visual impairment—Temozolomide—skin cancer	0.000755	0.00189	CcSEcCtD
Dorzolamide—Sinusitis—Fluorouracil—skin cancer	0.000754	0.00189	CcSEcCtD
Dorzolamide—Erythema—Dactinomycin—skin cancer	0.000754	0.00189	CcSEcCtD
Dorzolamide—Pain in extremity—Docetaxel—skin cancer	0.000753	0.00189	CcSEcCtD
Dorzolamide—Agranulocytosis—Fluorouracil—skin cancer	0.00075	0.00188	CcSEcCtD
Dorzolamide—Diarrhoea—Vemurafenib—skin cancer	0.000745	0.00187	CcSEcCtD
Dorzolamide—Erythema multiforme—Temozolomide—skin cancer	0.000741	0.00186	CcSEcCtD
Dorzolamide—Urticaria—Imiquimod—skin cancer	0.000738	0.00185	CcSEcCtD
Dorzolamide—Abdominal pain—Imiquimod—skin cancer	0.000734	0.00184	CcSEcCtD
Dorzolamide—Body temperature increased—Imiquimod—skin cancer	0.000734	0.00184	CcSEcCtD
Dorzolamide—Tinnitus—Temozolomide—skin cancer	0.00073	0.00183	CcSEcCtD
Dorzolamide—CA4—lymph node—skin cancer	0.000722	0.00813	CbGeAlD
Dorzolamide—Dizziness—Vemurafenib—skin cancer	0.00072	0.00181	CcSEcCtD
Dorzolamide—Pharyngitis—Fluorouracil—skin cancer	0.000716	0.0018	CcSEcCtD
Dorzolamide—Cough—Bleomycin—skin cancer	0.000705	0.00177	CcSEcCtD
Dorzolamide—Vomiting—Vemurafenib—skin cancer	0.000692	0.00174	CcSEcCtD
Dorzolamide—Alopecia—Temozolomide—skin cancer	0.000692	0.00174	CcSEcCtD
Dorzolamide—Chest pain—Bleomycin—skin cancer	0.000688	0.00173	CcSEcCtD
Dorzolamide—Rash—Vemurafenib—skin cancer	0.000686	0.00172	CcSEcCtD
Dorzolamide—Dermatitis—Vemurafenib—skin cancer	0.000686	0.00172	CcSEcCtD
Dorzolamide—Hypersensitivity—Imiquimod—skin cancer	0.000684	0.00172	CcSEcCtD
Dorzolamide—Headache—Vemurafenib—skin cancer	0.000682	0.00171	CcSEcCtD
Dorzolamide—Erythema—Temozolomide—skin cancer	0.000682	0.00171	CcSEcCtD
Dorzolamide—Discomfort—Bleomycin—skin cancer	0.00068	0.00171	CcSEcCtD
Dorzolamide—Toxic epidermal necrolysis—Docetaxel—skin cancer	0.000678	0.0017	CcSEcCtD
Dorzolamide—Dysgeusia—Temozolomide—skin cancer	0.000668	0.00168	CcSEcCtD
Dorzolamide—Asthenia—Imiquimod—skin cancer	0.000666	0.00167	CcSEcCtD
Dorzolamide—Confusional state—Bleomycin—skin cancer	0.000665	0.00167	CcSEcCtD
Dorzolamide—CYP3A4—female reproductive system—skin cancer	0.00066	0.00743	CbGeAlD
Dorzolamide—Oedema—Bleomycin—skin cancer	0.00066	0.00166	CcSEcCtD
Dorzolamide—Anaphylactic shock—Bleomycin—skin cancer	0.00066	0.00166	CcSEcCtD
Dorzolamide—Back pain—Temozolomide—skin cancer	0.000659	0.00166	CcSEcCtD
Dorzolamide—Pruritus—Imiquimod—skin cancer	0.000657	0.00165	CcSEcCtD
Dorzolamide—Nausea—Vemurafenib—skin cancer	0.000647	0.00162	CcSEcCtD
Dorzolamide—Arrhythmia—Fluorouracil—skin cancer	0.000645	0.00162	CcSEcCtD
Dorzolamide—Vision blurred—Temozolomide—skin cancer	0.000643	0.00161	CcSEcCtD
Dorzolamide—Bronchospasm—Docetaxel—skin cancer	0.00064	0.00161	CcSEcCtD
Dorzolamide—Alopecia—Fluorouracil—skin cancer	0.000638	0.0016	CcSEcCtD
Dorzolamide—Diarrhoea—Imiquimod—skin cancer	0.000635	0.00159	CcSEcCtD
Dorzolamide—Discomfort—Dactinomycin—skin cancer	0.000634	0.00159	CcSEcCtD
Dorzolamide—Angina pectoris—Docetaxel—skin cancer	0.000634	0.00159	CcSEcCtD
Dorzolamide—Anorexia—Bleomycin—skin cancer	0.000629	0.00158	CcSEcCtD
Dorzolamide—Erythema—Fluorouracil—skin cancer	0.000628	0.00158	CcSEcCtD
Dorzolamide—Angioedema—Temozolomide—skin cancer	0.000623	0.00156	CcSEcCtD
Dorzolamide—Hypotension—Bleomycin—skin cancer	0.000616	0.00155	CcSEcCtD
Dorzolamide—Oedema—Dactinomycin—skin cancer	0.000615	0.00154	CcSEcCtD
Dorzolamide—Dizziness—Imiquimod—skin cancer	0.000614	0.00154	CcSEcCtD
Dorzolamide—Vertigo—Temozolomide—skin cancer	0.000613	0.00154	CcSEcCtD
Dorzolamide—Palpitations—Temozolomide—skin cancer	0.000603	0.00151	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Bleomycin—skin cancer	0.000601	0.00151	CcSEcCtD
Dorzolamide—CA2—lymph node—skin cancer	0.000599	0.00674	CbGeAlD
Dorzolamide—Cough—Temozolomide—skin cancer	0.000595	0.00149	CcSEcCtD
Dorzolamide—Paraesthesia—Bleomycin—skin cancer	0.000592	0.00149	CcSEcCtD
Dorzolamide—Vision blurred—Fluorouracil—skin cancer	0.000592	0.00149	CcSEcCtD
Dorzolamide—Vomiting—Imiquimod—skin cancer	0.00059	0.00148	CcSEcCtD
Dorzolamide—Weight decreased—Docetaxel—skin cancer	0.000589	0.00148	CcSEcCtD
Dorzolamide—Hypertension—Temozolomide—skin cancer	0.000589	0.00148	CcSEcCtD
Dorzolamide—Dyspnoea—Bleomycin—skin cancer	0.000588	0.00148	CcSEcCtD
Dorzolamide—Anorexia—Dactinomycin—skin cancer	0.000586	0.00147	CcSEcCtD
Dorzolamide—Rash—Imiquimod—skin cancer	0.000585	0.00147	CcSEcCtD
Dorzolamide—Dermatitis—Imiquimod—skin cancer	0.000585	0.00147	CcSEcCtD
Dorzolamide—Headache—Imiquimod—skin cancer	0.000582	0.00146	CcSEcCtD
Dorzolamide—Arthralgia—Temozolomide—skin cancer	0.00058	0.00146	CcSEcCtD
Dorzolamide—Anxiety—Temozolomide—skin cancer	0.000578	0.00145	CcSEcCtD
Dorzolamide—Stevens-Johnson syndrome—Docetaxel—skin cancer	0.000575	0.00144	CcSEcCtD
Dorzolamide—Discomfort—Temozolomide—skin cancer	0.000573	0.00144	CcSEcCtD
Dorzolamide—Decreased appetite—Bleomycin—skin cancer	0.000573	0.00144	CcSEcCtD
Dorzolamide—Acute coronary syndrome—Docetaxel—skin cancer	0.000572	0.00144	CcSEcCtD
Dorzolamide—Myocardial infarction—Docetaxel—skin cancer	0.000569	0.00143	CcSEcCtD
Dorzolamide—Dry mouth—Temozolomide—skin cancer	0.000568	0.00143	CcSEcCtD
Dorzolamide—Pain—Bleomycin—skin cancer	0.000564	0.00142	CcSEcCtD
Dorzolamide—Conjunctivitis—Docetaxel—skin cancer	0.000564	0.00142	CcSEcCtD
Dorzolamide—Confusional state—Temozolomide—skin cancer	0.000561	0.00141	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Dactinomycin—skin cancer	0.00056	0.00141	CcSEcCtD
Dorzolamide—Oedema—Temozolomide—skin cancer	0.000556	0.0014	CcSEcCtD
Dorzolamide—Anaphylactic shock—Temozolomide—skin cancer	0.000556	0.0014	CcSEcCtD
Dorzolamide—Nausea—Imiquimod—skin cancer	0.000552	0.00138	CcSEcCtD
Dorzolamide—Epistaxis—Docetaxel—skin cancer	0.000547	0.00137	CcSEcCtD
Dorzolamide—Feeling abnormal—Bleomycin—skin cancer	0.000544	0.00136	CcSEcCtD
Dorzolamide—Agranulocytosis—Docetaxel—skin cancer	0.000541	0.00136	CcSEcCtD
Dorzolamide—Hyperhidrosis—Temozolomide—skin cancer	0.000538	0.00135	CcSEcCtD
Dorzolamide—Chest pain—Fluorouracil—skin cancer	0.000535	0.00134	CcSEcCtD
Dorzolamide—Decreased appetite—Dactinomycin—skin cancer	0.000535	0.00134	CcSEcCtD
Dorzolamide—Fatigue—Dactinomycin—skin cancer	0.00053	0.00133	CcSEcCtD
Dorzolamide—Anorexia—Temozolomide—skin cancer	0.00053	0.00133	CcSEcCtD
Dorzolamide—Discomfort—Fluorouracil—skin cancer	0.000528	0.00133	CcSEcCtD
Dorzolamide—Pain—Dactinomycin—skin cancer	0.000526	0.00132	CcSEcCtD
Dorzolamide—Urticaria—Bleomycin—skin cancer	0.000524	0.00132	CcSEcCtD
Dorzolamide—Body temperature increased—Bleomycin—skin cancer	0.000521	0.00131	CcSEcCtD
Dorzolamide—Confusional state—Fluorouracil—skin cancer	0.000517	0.0013	CcSEcCtD
Dorzolamide—Pharyngitis—Docetaxel—skin cancer	0.000517	0.0013	CcSEcCtD
Dorzolamide—Oedema—Fluorouracil—skin cancer	0.000513	0.00129	CcSEcCtD
Dorzolamide—Anaphylactic shock—Fluorouracil—skin cancer	0.000513	0.00129	CcSEcCtD
Dorzolamide—Feeling abnormal—Dactinomycin—skin cancer	0.000507	0.00127	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Temozolomide—skin cancer	0.000507	0.00127	CcSEcCtD
Dorzolamide—Insomnia—Temozolomide—skin cancer	0.000503	0.00126	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Dactinomycin—skin cancer	0.000503	0.00126	CcSEcCtD
Dorzolamide—Visual impairment—Docetaxel—skin cancer	0.000502	0.00126	CcSEcCtD
Dorzolamide—Paraesthesia—Temozolomide—skin cancer	0.0005	0.00125	CcSEcCtD
Dorzolamide—Dyspnoea—Temozolomide—skin cancer	0.000496	0.00125	CcSEcCtD
Dorzolamide—Somnolence—Temozolomide—skin cancer	0.000495	0.00124	CcSEcCtD
Dorzolamide—Erythema multiforme—Docetaxel—skin cancer	0.000492	0.00124	CcSEcCtD
Dorzolamide—Dyspepsia—Temozolomide—skin cancer	0.00049	0.00123	CcSEcCtD
Dorzolamide—Anorexia—Fluorouracil—skin cancer	0.000489	0.00123	CcSEcCtD
Dorzolamide—Abdominal pain—Dactinomycin—skin cancer	0.000486	0.00122	CcSEcCtD
Dorzolamide—Body temperature increased—Dactinomycin—skin cancer	0.000486	0.00122	CcSEcCtD
Dorzolamide—Hypersensitivity—Bleomycin—skin cancer	0.000486	0.00122	CcSEcCtD
Dorzolamide—Decreased appetite—Temozolomide—skin cancer	0.000484	0.00121	CcSEcCtD
Dorzolamide—Fatigue—Temozolomide—skin cancer	0.00048	0.0012	CcSEcCtD
Dorzolamide—Hypotension—Fluorouracil—skin cancer	0.000479	0.0012	CcSEcCtD
Dorzolamide—Pain—Temozolomide—skin cancer	0.000476	0.00119	CcSEcCtD
Dorzolamide—Asthenia—Bleomycin—skin cancer	0.000473	0.00119	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Fluorouracil—skin cancer	0.000467	0.00117	CcSEcCtD
Dorzolamide—Pruritus—Bleomycin—skin cancer	0.000467	0.00117	CcSEcCtD
Dorzolamide—Arrhythmia—Docetaxel—skin cancer	0.000465	0.00117	CcSEcCtD
Dorzolamide—Insomnia—Fluorouracil—skin cancer	0.000464	0.00116	CcSEcCtD
Dorzolamide—Paraesthesia—Fluorouracil—skin cancer	0.00046	0.00116	CcSEcCtD
Dorzolamide—Alopecia—Docetaxel—skin cancer	0.00046	0.00116	CcSEcCtD
Dorzolamide—Feeling abnormal—Temozolomide—skin cancer	0.000459	0.00115	CcSEcCtD
Dorzolamide—Dyspnoea—Fluorouracil—skin cancer	0.000457	0.00115	CcSEcCtD
Dorzolamide—Somnolence—Fluorouracil—skin cancer	0.000456	0.00114	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Temozolomide—skin cancer	0.000455	0.00114	CcSEcCtD
Dorzolamide—Erythema—Docetaxel—skin cancer	0.000453	0.00114	CcSEcCtD
Dorzolamide—Hypersensitivity—Dactinomycin—skin cancer	0.000453	0.00114	CcSEcCtD
Dorzolamide—Dyspepsia—Fluorouracil—skin cancer	0.000451	0.00113	CcSEcCtD
Dorzolamide—Decreased appetite—Fluorouracil—skin cancer	0.000446	0.00112	CcSEcCtD
Dorzolamide—Dysgeusia—Docetaxel—skin cancer	0.000444	0.00111	CcSEcCtD
Dorzolamide—Urticaria—Temozolomide—skin cancer	0.000442	0.00111	CcSEcCtD
Dorzolamide—Asthenia—Dactinomycin—skin cancer	0.000441	0.00111	CcSEcCtD
Dorzolamide—Body temperature increased—Temozolomide—skin cancer	0.00044	0.0011	CcSEcCtD
Dorzolamide—Abdominal pain—Temozolomide—skin cancer	0.00044	0.0011	CcSEcCtD
Dorzolamide—Back pain—Docetaxel—skin cancer	0.000439	0.0011	CcSEcCtD
Dorzolamide—Pain—Fluorouracil—skin cancer	0.000438	0.0011	CcSEcCtD
Dorzolamide—Feeling abnormal—Fluorouracil—skin cancer	0.000422	0.00106	CcSEcCtD
Dorzolamide—Diarrhoea—Dactinomycin—skin cancer	0.000421	0.00106	CcSEcCtD
Dorzolamide—Vomiting—Bleomycin—skin cancer	0.000419	0.00105	CcSEcCtD
Dorzolamide—Rash—Bleomycin—skin cancer	0.000416	0.00104	CcSEcCtD
Dorzolamide—Dermatitis—Bleomycin—skin cancer	0.000416	0.00104	CcSEcCtD
Dorzolamide—Hypersensitivity—Temozolomide—skin cancer	0.00041	0.00103	CcSEcCtD
Dorzolamide—Urticaria—Fluorouracil—skin cancer	0.000407	0.00102	CcSEcCtD
Dorzolamide—Syncope—Docetaxel—skin cancer	0.000407	0.00102	CcSEcCtD
Dorzolamide—Body temperature increased—Fluorouracil—skin cancer	0.000405	0.00102	CcSEcCtD
Dorzolamide—Palpitations—Docetaxel—skin cancer	0.000401	0.00101	CcSEcCtD
Dorzolamide—Asthenia—Temozolomide—skin cancer	0.000399	0.001	CcSEcCtD
Dorzolamide—Loss of consciousness—Docetaxel—skin cancer	0.000398	0.001	CcSEcCtD
Dorzolamide—Cough—Docetaxel—skin cancer	0.000396	0.000993	CcSEcCtD
Dorzolamide—Pruritus—Temozolomide—skin cancer	0.000394	0.000988	CcSEcCtD
Dorzolamide—Nausea—Bleomycin—skin cancer	0.000392	0.000984	CcSEcCtD
Dorzolamide—Hypertension—Docetaxel—skin cancer	0.000391	0.000983	CcSEcCtD
Dorzolamide—Vomiting—Dactinomycin—skin cancer	0.000391	0.000982	CcSEcCtD
Dorzolamide—Rash—Dactinomycin—skin cancer	0.000388	0.000974	CcSEcCtD
Dorzolamide—Arthralgia—Docetaxel—skin cancer	0.000386	0.000969	CcSEcCtD
Dorzolamide—Chest pain—Docetaxel—skin cancer	0.000386	0.000969	CcSEcCtD
Dorzolamide—Diarrhoea—Temozolomide—skin cancer	0.000381	0.000956	CcSEcCtD
Dorzolamide—Hypersensitivity—Fluorouracil—skin cancer	0.000378	0.000948	CcSEcCtD
Dorzolamide—Dry mouth—Docetaxel—skin cancer	0.000378	0.000948	CcSEcCtD
Dorzolamide—Confusional state—Docetaxel—skin cancer	0.000373	0.000937	CcSEcCtD
Dorzolamide—Anaphylactic shock—Docetaxel—skin cancer	0.00037	0.000929	CcSEcCtD
Dorzolamide—Oedema—Docetaxel—skin cancer	0.00037	0.000929	CcSEcCtD
Dorzolamide—Dizziness—Temozolomide—skin cancer	0.000368	0.000924	CcSEcCtD
Dorzolamide—Nausea—Dactinomycin—skin cancer	0.000365	0.000917	CcSEcCtD
Dorzolamide—Shock—Docetaxel—skin cancer	0.000364	0.000914	CcSEcCtD
Dorzolamide—Pruritus—Fluorouracil—skin cancer	0.000363	0.000911	CcSEcCtD
Dorzolamide—Vomiting—Temozolomide—skin cancer	0.000354	0.000888	CcSEcCtD
Dorzolamide—Anorexia—Docetaxel—skin cancer	0.000353	0.000885	CcSEcCtD
Dorzolamide—Rash—Temozolomide—skin cancer	0.000351	0.000881	CcSEcCtD
Dorzolamide—Diarrhoea—Fluorouracil—skin cancer	0.000351	0.000881	CcSEcCtD
Dorzolamide—Dermatitis—Temozolomide—skin cancer	0.000351	0.00088	CcSEcCtD
Dorzolamide—Headache—Temozolomide—skin cancer	0.000349	0.000875	CcSEcCtD
Dorzolamide—Hypotension—Docetaxel—skin cancer	0.000346	0.000868	CcSEcCtD
Dorzolamide—Dizziness—Fluorouracil—skin cancer	0.000339	0.000851	CcSEcCtD
Dorzolamide—Musculoskeletal discomfort—Docetaxel—skin cancer	0.000337	0.000846	CcSEcCtD
Dorzolamide—Insomnia—Docetaxel—skin cancer	0.000335	0.00084	CcSEcCtD
Dorzolamide—Paraesthesia—Docetaxel—skin cancer	0.000332	0.000834	CcSEcCtD
Dorzolamide—Nausea—Temozolomide—skin cancer	0.000331	0.00083	CcSEcCtD
Dorzolamide—Dyspnoea—Docetaxel—skin cancer	0.00033	0.000828	CcSEcCtD
Dorzolamide—Somnolence—Docetaxel—skin cancer	0.000329	0.000826	CcSEcCtD
Dorzolamide—Vomiting—Fluorouracil—skin cancer	0.000326	0.000818	CcSEcCtD
Dorzolamide—Dyspepsia—Docetaxel—skin cancer	0.000326	0.000818	CcSEcCtD
Dorzolamide—Rash—Fluorouracil—skin cancer	0.000323	0.000812	CcSEcCtD
Dorzolamide—Dermatitis—Fluorouracil—skin cancer	0.000323	0.000811	CcSEcCtD
Dorzolamide—Decreased appetite—Docetaxel—skin cancer	0.000322	0.000808	CcSEcCtD
Dorzolamide—Headache—Fluorouracil—skin cancer	0.000321	0.000806	CcSEcCtD
Dorzolamide—Fatigue—Docetaxel—skin cancer	0.000319	0.000801	CcSEcCtD
Dorzolamide—Pain—Docetaxel—skin cancer	0.000316	0.000794	CcSEcCtD
Dorzolamide—Feeling abnormal—Docetaxel—skin cancer	0.000305	0.000766	CcSEcCtD
Dorzolamide—Nausea—Fluorouracil—skin cancer	0.000305	0.000764	CcSEcCtD
Dorzolamide—Gastrointestinal pain—Docetaxel—skin cancer	0.000303	0.00076	CcSEcCtD
Dorzolamide—Body temperature increased—Docetaxel—skin cancer	0.000293	0.000734	CcSEcCtD
Dorzolamide—Abdominal pain—Docetaxel—skin cancer	0.000293	0.000734	CcSEcCtD
Dorzolamide—Hypersensitivity—Docetaxel—skin cancer	0.000273	0.000684	CcSEcCtD
Dorzolamide—Asthenia—Docetaxel—skin cancer	0.000265	0.000666	CcSEcCtD
Dorzolamide—Pruritus—Docetaxel—skin cancer	0.000262	0.000657	CcSEcCtD
Dorzolamide—Diarrhoea—Docetaxel—skin cancer	0.000253	0.000636	CcSEcCtD
Dorzolamide—Dizziness—Docetaxel—skin cancer	0.000245	0.000614	CcSEcCtD
Dorzolamide—Vomiting—Docetaxel—skin cancer	0.000235	0.000591	CcSEcCtD
Dorzolamide—Rash—Docetaxel—skin cancer	0.000233	0.000586	CcSEcCtD
Dorzolamide—Dermatitis—Docetaxel—skin cancer	0.000233	0.000585	CcSEcCtD
Dorzolamide—Headache—Docetaxel—skin cancer	0.000232	0.000582	CcSEcCtD
Dorzolamide—Nausea—Docetaxel—skin cancer	0.00022	0.000552	CcSEcCtD
